Increasing Efficiency and Quality by Consolidation of Clinical Chemistry and Immunochemistry Systems with MODULAR ANALYTICS SWA

Table 3

Sample related carryover with high priority test option off. With high priority test option on, sample carryover cannot occur. (For explanation see results section, sample-related carryover.)

Analyte	Expected values	10% of lower decision level	Lower detection limit	Ratio high : low	Max. diff low1–low5(if >2SD)	Material	Relevant Carryover, high priority off	Relevant Carryover, high priority on
AFP	<6.2 𝑛=15g/l	0.62 𝑛>10g/l	0.6 (ℎ1,ℎ2,ℎ3)g/l	40871	0.62	Native	yes	No
CEA	<4.6 ⋯g/l	0.46 ℎ1ℎ2ℎ3g/l	0.2 𝛽g/l	16197	7.64	Spiked	yes	No
PSA	<4 𝑛g/l	0.4 𝛽g/l	0.002 𝜇g/l	756	0.20	Spiked	yes	No
Ferritin	~15–400 𝜇g/l	1.5 𝜇g/l	0.5 𝜇g/l	969	2.00	Spiked	no	No
HCG +	<5 mIU/ml	0.5 mIU/ml	0.1 mIU/ml	117000	1.30	Native	yes	No
a-HAV	<20 IU/l	2.0 IU/l	3.0 IU/l	1184	0.25	Native	no	No
HbsAg	<1.0 COI	0.1 COI		285106	0.44	native	yes	No